These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 36263177)
1. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability. Xu Y; Zhou J; Li L; Yang W; Zhang Z; Zhang K; Ma K; Xie H; Zhang Z; Cai L; Gong Y; Gong K Int J Biol Sci; 2022; 18(15):5943-5962. PubMed ID: 36263177 [TBL] [Abstract][Full Text] [Related]
2. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515 [TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma. Wang F; Liao Y; Zhang M; Zhu Y; Wang W; Cai H; Liang J; Song F; Hou C; Huang S; Zhang Y; Wang C; Hou J Oncogene; 2021 Jun; 40(22):3885-3898. PubMed ID: 33972683 [TBL] [Abstract][Full Text] [Related]
4. m Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060 [TBL] [Abstract][Full Text] [Related]
5. The m He Y; Chen Y; Li Z; Wu C J Cancer Res Clin Oncol; 2024 Jan; 150(2):30. PubMed ID: 38270643 [TBL] [Abstract][Full Text] [Related]
6. NOP2-mediated 5-methylcytosine modification of APOL1 messenger RNA activates PI3K-Akt and facilitates clear cell renal cell carcinoma progression. Tian J; Gao J; Cheng C; Xu Z; Chen X; Wu Y; Fu G; Jin B Int J Biol Sci; 2024; 20(12):4853-4871. PubMed ID: 39309431 [No Abstract] [Full Text] [Related]
7. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1. Yang W; Zhang K; Li L; Xu Y; Ma K; Xie H; Zhou J; Cai L; Gong Y; Gong K J Exp Clin Cancer Res; 2021 Mar; 40(1):92. PubMed ID: 33691743 [TBL] [Abstract][Full Text] [Related]
8. FTO facilitates cancer metastasis by modifying the m Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739 [TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1α signalling axis. Zhuang C; Zhuang C; Luo X; Huang X; Yao L; Li J; Li Y; Xiong T; Ye J; Zhang F; Gui Y J Cell Mol Med; 2019 Mar; 23(3):2163-2173. PubMed ID: 30648791 [TBL] [Abstract][Full Text] [Related]
10. LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis. Fu Y; Liu L; Wu H; Zheng Y; Zhan H; Li L Mol Cell Biochem; 2024 Mar; 479(3):553-566. PubMed ID: 37120495 [TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway. Tan D; Miao D; Zhao C; Shi J; Lv Q; Lu F; Ruan H; Xiong Z; Zhang X Cell Death Dis; 2024 Jul; 15(7):520. PubMed ID: 39039052 [TBL] [Abstract][Full Text] [Related]
12. TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma. Xu Y; Li L; Yang W; Zhang K; Zhang Z; Yu C; Qiu J; Cai L; Gong Y; Zhang Z; Zhou J; Gong K J Exp Clin Cancer Res; 2023 Jul; 42(1):159. PubMed ID: 37415241 [TBL] [Abstract][Full Text] [Related]
13. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer. Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402 [TBL] [Abstract][Full Text] [Related]
14. MiR-155 regulates m Yang W; Xie L; Wang P; Zhuang C Cell Signal; 2022 Mar; 91():110217. PubMed ID: 34921979 [TBL] [Abstract][Full Text] [Related]
15. Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA. Pan X; Huang B; Ma Q; Ren J; Liu Y; Wang C; Zhang D; Fu J; Ran L; Yu T; Li H; Wang X; Yang F; Liang C; Zhang Y; Wang S; Ren J; Li W; Wang Y; Xiao B Clin Transl Med; 2022 Jul; 12(7):e994. PubMed ID: 35876041 [TBL] [Abstract][Full Text] [Related]
16. IGF2BP2 inhibits invasion and migration of clear cell renal cell carcinoma via targeting Netrin-4 in an m Wang G; Zhuang T; Zhen F; Zhang C; Wang Q; Miao X; Qi N; Yao R Mol Carcinog; 2024 Aug; 63(8):1572-1587. PubMed ID: 38780170 [TBL] [Abstract][Full Text] [Related]
17. Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival. Zhao J; Lu L Recent Pat Anticancer Drug Discov; 2021; 16(3):363-376. PubMed ID: 33563180 [TBL] [Abstract][Full Text] [Related]
18. m Liang D; Lin WJ; Ren M; Qiu J; Yang C; Wang X; Li N; Zeng T; Sun K; You L; Yan L; Wang W Autophagy; 2022 Jun; 18(6):1318-1337. PubMed ID: 34657574 [TBL] [Abstract][Full Text] [Related]
19. Autophagy of the m Cui YH; Yang S; Wei J; Shea CR; Zhong W; Wang F; Shah P; Kibriya MG; Cui X; Ahsan H; He C; He YY Nat Commun; 2021 Apr; 12(1):2183. PubMed ID: 33846348 [TBL] [Abstract][Full Text] [Related]
20. The antagonistic effect of FTO on METTL14 promotes AKT3 m Wei R; Zhao F; Kong L; Pu Y; Li Y; Zang C J Cancer Res Clin Oncol; 2024 Mar; 150(3):131. PubMed ID: 38491196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]